Chang Jen Jiang
Fortune : 44 464 $ au 30/09/2026
Fortune : 44 464 $ au 30/09/2026
Dr. Chang Jen Jiang, MD, is on the Board of Directors at BioFirst Corp., BioLite, Inc. and ABVC BioPharma, Inc. Dr. Jiang was previously employed as a Head-Pediatrics, Hematology and Oncology by Mackay Memorial Hospital.
He received his doctorate degree from Taipei Medical University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABVC BIOPHARMA, INC. 0,16% | 27/02/2026 | 41 947 ( 0,16% ) | 44 464 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ABVC BIOPHARMA, INC. | Directeur/Membre du Conseil | - |
| BIOFIRST CORP | Directeur/Membre du Conseil | 01/01/2015 |
BioLite, Inc.
BioLite, Inc. Electronics/AppliancesConsumer Durables Develops, manufactures and markets consumer energy products | Directeur/Membre du Conseil | 01/01/2013 |
| Sociétés | Poste | Fin |
|---|---|---|
Mackay Memorial Hospital | Corporate Officer/Principal | 01/01/1994 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Taipei Medical University
Taipei Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABVC BioPharma, Inc.
ABVC BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops drugs and medical devices in the fields of oncology, ophthalmology and central nervous system | Health Technology |
Mackay Memorial Hospital | |
BioFirst Corp.
BioFirst Corp. BiotechnologyHealth Technology Engages in the research and development, manufacture and sale of medical equipment and medicines | Health Technology |
BioLite, Inc.
BioLite, Inc. Electronics/AppliancesConsumer Durables Develops, manufactures and markets consumer energy products | Consumer Durables |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national